
### [NCIT:C3784](http://purl.obolibrary.org/obo/NCIT_C3784)
**Label:** Basal Cell Neoplasm

**Subclasses:** [NCIT:C5568](http://purl.obolibrary.org/obo/NCIT_C5568) (Skin Nodulo-Ulcerative Basal Cell Carcinoma), [NCIT:C27539](http://purl.obolibrary.org/obo/NCIT_C27539) (Skin Infiltrating Basal Cell Carcinoma), [NCIT:C7586](http://purl.obolibrary.org/obo/NCIT_C7586) (Malignant Basal Cell Neoplasm), [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014) (Lip Basal Cell Carcinoma), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C27535](http://purl.obolibrary.org/obo/NCIT_C27535) (Skin Adenoid Basal Cell Carcinoma), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), [NCIT:C27537](http://purl.obolibrary.org/obo/NCIT_C27537) (Skin Cystic Basal Cell Carcinoma), [NCIT:C27536](http://purl.obolibrary.org/obo/NCIT_C27536) (Skin Clear Cell Basal Cell Carcinoma), [NCIT:C6082](http://purl.obolibrary.org/obo/NCIT_C6082) (External Ear Basal Cell Carcinoma), [NCIT:C6381](http://purl.obolibrary.org/obo/NCIT_C6381) (Vulvar Basal Cell Carcinoma), [NCIT:C27182](http://purl.obolibrary.org/obo/NCIT_C27182) (Skin Morphea-Type (Sclerosing) Basal Cell Carcinoma), [NCIT:C38109](http://purl.obolibrary.org/obo/NCIT_C38109) (Skin Basal Cell Carcinoma with Adnexal Differentiation), [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), [NCIT:C5616](http://purl.obolibrary.org/obo/NCIT_C5616) (Skin Nodular Solid Basal Cell Carcinoma), [NCIT:C54665](http://purl.obolibrary.org/obo/NCIT_C54665) (Skin Keratotic Basal Cell Carcinoma), [NCIT:C5950](http://purl.obolibrary.org/obo/NCIT_C5950) (Salivary Gland Basal Cell Adenoma), [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma), [NCIT:C8205](http://purl.obolibrary.org/obo/NCIT_C8205) (Stage III Lip Basal Cell Carcinoma), [NCIT:C3678](http://purl.obolibrary.org/obo/NCIT_C3678) (Salivary Gland Basal Cell Adenocarcinoma), [NCIT:C4346](http://purl.obolibrary.org/obo/NCIT_C4346) (Skin Basal Cell Carcinoma with Sebaceous Differentiation), [NCIT:C4743](http://purl.obolibrary.org/obo/NCIT_C4743) (Benign Basal Cell Neoplasm), [NCIT:C9359](http://purl.obolibrary.org/obo/NCIT_C9359) (Skin Pigmented Basal Cell Carcinoma), [NCIT:C8201](http://purl.obolibrary.org/obo/NCIT_C8201) (Stage II Lip Basal Cell Carcinoma), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), [NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma), [NCIT:C38110](http://purl.obolibrary.org/obo/NCIT_C38110) (Skin Signet Ring Cell Basal Cell Carcinoma), [NCIT:C38111](http://purl.obolibrary.org/obo/NCIT_C38111) (Skin Sarcomatoid Basal Cell Carcinoma), [NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma), [NCIT:C62282](http://purl.obolibrary.org/obo/NCIT_C62282) (Skin Nodular Basal Cell Carcinoma), [NCIT:C2922](http://purl.obolibrary.org/obo/NCIT_C2922) (Skin Basosquamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39128](http://purl.obolibrary.org/obo/NCIT_C39128) (IL7 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 43.69%


